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ABSTRACT The zinc-protease a disintegrin-like and metalloprotease with thrombospondin type I repeats (ADAMTS13)
cleaves the Tyr1605-Met1606 peptide bond of von Willebrand factor (VWF), avoiding the accumulation of ultra large VWF
multimers. Hydrolysis by ADAMTS13 of a VWF analog (Asp1596-Arg1668 peptide, ﬂuorescence energy transfer substrate
[FRETS]-VWF73) was investigated by a ﬂuorescence quenching method (FRETS method) from 15C to 45C and pH values
from 4.5 to 10.5. The catalysis was inﬂuenced by two ionizable groups, whose pKa values were equal to 6.41 6 0.08 (ionization
enthalpy ¼ 32.6 6 1.7 kJ/mol) and 4 6 0.1 (ionization enthalpy ¼ 3.8 6 0.4 kJ/mol), whereas these values were equal to 6 6
0.1 and 4.1 6 0.1, respectively, in Co21-substituted ADAMTS13. The catalytic process of FRETS-VWF73 hydrolysis showed
negative activation entropy (144 kJ/mol), suggesting that the transition state becomes more ordered than the ground state of
the reactants. The kcat/Km values were not linearly correlated with temperature, as expression of change of the kinetic
‘‘stickiness’’ of the substrate. The Met1606-Arg1668 peptide product acted as hyperbolic mixed-type inhibitor of FRETS-VWF73
hydrolysis. Asp1653, Glu1655, Glu1660, Asp1663, together with the hydrophilic side chain of Thr1656 were shown to form a ‘‘hot
spot’’ in the VWF A2 sequence, which drives the molecular recognition and allosteric regulation of binding to ADAMTS13. The
interaction of the Met1606-Arg1668 region of VWF with ADAMTS13 involves basic residues of the protease and is thus
progressively inhibited at pH values .8.50. A molecular model of the FRETS-VWF73 showed that the substrate can ﬁt into the
active site only if ADAMTS13 assumes a C-like shape and, interacting with the acidic 1653–1668 region of VWF, properly
orients the Tyr1605-Met1606 peptide bond for the cleavage by the zinc-aquo complex in the active site.
INTRODUCTION
A disintegrin-like and metalloprotease with thrombospondin
type I repeats (ADAMTS13) is a member of the ADAMTS
family of metalloproteases (1) constituted by a multidomain
enzyme that cleaves von Willebrand factor (VWF) at the
peptide bond between Tyr1605 and Met1606, located in the
VWF A2 domain. On cleavage, one N-terminal and one
C-terminal fragment are generated from the VWF monomer
(2–5). Pathological perturbations of the ADAMTS13/VWF
proteolytic interaction are responsible for either thrombotic
microangiopathies or hemorrhagic syndromes in type 2A von
Willebrand diseases (6–11). Modulation of the ADAMTS13/
VWF interaction is critical for an efﬁcient proteolysis and
involves both VWF and ADAMTS13. The latter binds to
VWF under static conditions and under conditions of venous
(2.5 dyn/cm2) and arterial (30 dyn/cm2) shear stress. This
interaction, however, is unproductive for proteolysis unless
shear stress is high enough to stretch VWF and expose the
buried A2 domain for cleavage (12–15). Under static con-
ditions, ADAMTS13 cleaves VWF only under denaturing
conditions (8), whereas under conditions of high shear stress
found in the microvasculature VWF proteolysis is extremely
rapid and occurs without denaturing agents (3,16,17). Fluid
shear stress alters the conformation of VWF so that the
binding and catalysis of ADAMTS13 takes place at the VWF
A2 domain (13). The Tyr1605-Met1606 peptide bond is in fact
buried within the VWF A2 domain under static conditions
and cannot be recognized by ADAMTS13 (12,14,15). Re-
cent studies have also shown that the binding of the platelet
receptor of VWF, i.e., the Glycoprotein Ib (GpIba), is able to
induce conformational changes in the A1–A2 domains of
VWF, responsible for an enhanced rate of cleavage by the
metalloprotease (18,19). On the contrary, binding of chloride
ions to the A1 domain of VWF inhibits proteolysis by
ADAMTS13, inducing conformational transitions in the
A1–A2 VWF domains, which make the cleavable peptide
bond in the A2 domain unavailable to proteolysis (8,20,21).
Thus, only in the presence of speciﬁc biophysical or bio-
chemical factors, VWF molecules assume a proper confor-
mational state available to proteolytic attack by ADAMTS13.
Knowledge of the factors that can modulate this interaction is
particularly relevant, as it may help to unravel the mecha-
nisms through which the reaction is inhibited in several
clinical settings. Among biochemical factors, protons play a
relevant role in modulating the activity of metalloproteases
and pH may change in vivo, having different values inside
and outside the cellular compartment. Previous data showed
that the velocity of ADAMTS13 hydrolysis of a synthetic
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peptide shows a maximum under acidic conditions, although
no systematic study of the pH-dependence of steady state
kinetic parameters was carried out (22). This pH-dependent
activity of ADAMTS13 seems rather unusual if compared to
other zinc-proteases, and especially matrix metalloproteases
and ADAMS (23,24), which show maximum activity at pH
values.7. The scenario of the pH-dependence of the activity
of ADAMTS13 is complicated further by previous ﬁndings
showing that under mild denaturing conditions ADAMTS13
cleaves natural VWF multimers at a pH optimum .8 (8).
Unfortunately, both the need to use denaturing agents under
static conditions to investigate the ADAMTS13/VWF inter-
action and the multimeric nature of the substrate renders
practically impossible the study of the pH- and temperature-
dependence of the catalytic parameters of cleavage of native
VWF multimers. The discovery of a ﬂuorescent peptide
substrate spanning from Asp1596 to Arg1668 of the A2 domain
of VWF (ﬂuorescence energy transfer substrate [FRETS]-
VWF73) (22) makes feasible a systematic study of the
steady-state kinetic parameters for its hydrolysis as a function
of pH and temperature, that is still elusive. The use of this
ﬂuorescent substrate and the Fluorescence quenching method
(FRETS method) was applied to both native Zn21-
ADAMTS13 and artiﬁcially Co21- and Ni21-substituted
ADAMTS13 to investigate the effects of pH and temperature
on the protease activity of the enzyme. Finally, the use of
different peptides synthesized from the Asp1596-Arg1668
substrate sequence allowed us to investigate whether the in-
teraction with ADAMTS13 is allosterically regulated by in-
teractions with different regions of the substrate and whether
protons play a role in such a regulation. The aspect con-
cerning the pH-dependent modulation of ADAMTS13/VWF
interaction is physiologically relevant because after extrusion
from intracellular granules, VWF indeed may experience
large variations in environmental conditions, as pH and ionic
strength. These mechanistic studies allowed us to obtain
initial informations on the recognition and cleavage mecha-
nisms operating on the proteolytic processing of VWF by
ADAMTS13.
MATERIALS AND METHODS
Puriﬁcation of recombinant and plasma-derived
human ADAMTS13
ADAMTS13 used in this study was either a recombinant His-tagged form,
produced in HEK-293 cell line based on the reported gene sequence of the
enzyme (25) and puriﬁed as previously described (20) or derived from hu-
man plasma (provided by the Transfusion Center of the Catholic University
School of Medicine of Rome from outdated units of fresh frozen plasma).
The latter preparation was used for experiments dealing with exchange of the
catalytic zinc with cobalt ion. For this preparation the original step of the
puriﬁcation procedure, i.e., ammonium sulfate precipitation (20), was re-
placed by an afﬁnity chromatography using an anti-ADAMTS13 polyclonal
antibody. Brieﬂy, 1 mg of rabbit anti-human ADAMTS13 polyclonal anti-
body, raised against amino acids 1128–1427 of the enzyme, was purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). The puriﬁed IgGs were
immobilized through the carbohydrate moiety of the Fc region to 2 mL of
Afﬁ-Gel Hz Activated Support from Bio-Rad Laboratories (Hercules, CA)
according to the manufacturer’s procedure. One mM (ﬁnal concentration)
phenyl-methyl-sulfonyl-ﬂuoride (PMSF) was added to 1 L of outdated fresh
frozen plasma, which was percolated at 4C overnight on the Afﬁ-Gel Hz
resin coupled to anti-ADAMTS13 polyclonal antibody, at a ﬂow rate of 1.5
mL/min. After the entire amount of plasma was percolated, the column was
washed with 10 mM Hepes, 0.15 M NaCl, pH 7.40 until the absorbance at
280 nm was zeroed. The bound protein was eluted by 0.1 M glycine buffer,
pH 3. A small amount (200 mL) of 1 M Tris-HCl buffer pH 8.5 was pre-
viously added to the collecting test tubes to neutralize the pH of the glycine
buffer and obtain a ﬁnal pH value of ;7. The pooled material contained a
major component of ;180 kDa and minor additional bands, that were
eliminated following the previously described chromatographic procedures
(20). The ﬁnal material was tested by SDS-PAGE using a 4%–12% acryl-
amide gradient under reducing conditions, which showed a single band with
a molecular mass of ;180 kDa. The concentration of the puriﬁed enzyme
was determined using an E(280 nm) (mg/mL, 1 cm)¼ 1.45, calculated using
the method of Pace et al. (26). The puriﬁed enzyme was aliquoted and stored
at 80C in stock solutions at ;0.3 mg/mL containing 10 mM Hepes, 0.15
M NaCl, 5 mM CaCl2, pH 7.5.
Preparation of Co21-substituted ADAMTS13
Apo-ADAMTS13 was prepared by treating a solution of 100 mg of
ADAMTS13 in 10 mM sodium acetate, pH 5.5, with 5 mM-I,10-phenan-
throline for 1 h at 4C (ﬁnal volume, 1 mL). The enzyme solution was then
dialyzed against 2 L of 10 mM of 1,10-phenanthroline for 2 h, and then
against 4 L of 1 mM CoCl2 (99.999% pure; Sigma-Aldrich, Milano, Italy)
overnight. This CoCl2 solution and all subsequent buffers were made in glass-
distilled deionized water that had been additionally treated with Chelex100
(Bio-Rad). The efﬁciency of incorporation of Co21 into apo-ADAMTS13 was
checked by measuring the ratio between the concentration of ADAMTS13,
determined both spectrophotometrically (at 280 nm) and by a commercial
ELISA assay (Imubind ADAMTS13 antigen, American Diagnostica, In-
strumentation Laboratory, Milan, Italy), and its protease activity measured
by FRETS-VWF73. The concentrations of Co21- and Zn21-ADAMTS13
measured spectrophotometrically and by ELISA were in good agreement
(difference within 8% deviance). After the extraction of Zn21 ions from
ADAMTS13 and elimination of phenanthrolene by extensive dialysis, the
activity of the enzyme toward FRETS-VWF73 was completely absent. The
lack of any artiﬁcial inactivation of ADAMTS13 by the process of extracting
zinc was checked by re-incorporating zinc ions by extensive dialysis into the
catalytic site of the apo-enzyme and measuring its catalytic properties in
comparison with the untreated enzyme. Co21-ADAMTS13 preparation was
kept in buffer solutions containing a ﬁnal concentration of 100 mM CoCl2
and 5 mM CaCl2. Before any functional assay, Co
21-ADAMTS13 solutions
were freed from Co21 ion by gel ﬁltration on DG-10 columns (Bio-Rad)
equilibrated with appropriate buffer solution without cobalt chloride.
Determination of kinetic parameters of
FRETS-VWF cleavage by FRETS method
The substrate used for the enzymatic assays was DRE-A2pr(Nma)-APNL-
VYMVTG-A2pr(Dnp)-PASDEIKRLPGDIQVVPIGVGPNANVQELER-
IGWPNAPILIQDFETLPREAPDLVLQR, corresponding to the region from
D1596 to R1668 of VWF. Called FRETS-VWF73, the substrate was syn-
thesized by Thermo Electron Corporation GmbH (Ulm, Germany). When
ADAMTS13 cleaves the bond between Y10 and M11 in FRETS-VWF73,
the ﬂuorescence at lem between 420 and 460 nm and lex¼ 340 nm increases
in proportion to the release of Nma ﬂuorophore from the internal Dnp
quencher (see Fig. S1 in SupplementaryMaterial, Data S1). Other shorter not
ﬂuorescent peptides, that are Met1606-Phe1654, Met1606-Leu1657, Met1606-
Ala1661, Met1606-Leu1664, andMet1606-Arg1668 were synthesized by PRIMM
Mechanistic Studies on ADAMTS-13 2451
Biophysical Journal 95(5) 2450–2461
s.r.l. (Milano, Italy). The ﬂuorescent substrate was dissolved in 50% dime-
thylsulfoxide at a concentration of 5 mM. In the functional assays, the ﬁnal
concentration was always #0.05% (w/v), that did not affect the protease
activity. The hydrolyzed peptide was monitored by exciting the substrate at
340 nm and measuring the ﬂuorescence at 450 nm (bandwidth of 5 nm at
both excitation and emission wavelength). Assays were carried out in 5 mM
Na-acetate, 5 mM Bis-Tris, 5 mM Tris, 10 mM CHES, 150 mM NaCl, 25
mM CaCl2, over the pH range spanning from 4.5 to 10.5. This four buffer
system allowed to keep nearly constant the ionic strength of the solution over
the entire pH range. The Michaelis constants of FRETS-VWF73 hydrolysis
were calculated using 0.5–2.5 nM puriﬁed human ADAMTS13 and 1–20
mM FRETS-VWF73. The initial velocity of FRETS-VWF73 hydrolysis by
ADAMTS13 was computed by a linear regression of the initial 20–40 points
(r . 0.97) and always when not more than 5% (1 mM) of the substrate was
hydrolyzed, according to the principles of steady-state enzyme kinetics (27).
Thus, the reference curve for the conversion of the ﬂuorescence signal into
concentration of cleaved substrate was carried out constructing a reference
curve (8 dilutions, dilution factor¼ 1.5) with a solution of FRETS-VWF73 at
known concentration (1 mM) exhaustively hydrolyzed for 24 h by 0.5 nM
ADAMTS13. Furthermore, the emission spectrum of the hydrolyzed
FRETS-VWF73 was analyzed between 400 and 500 nm at pH values
spanning from 4.5 to 10.50, and at different temperatures ranging from 15C
to 45C, to assess any inﬂuence of these parameters on the ﬂuorescence
properties of the product. The kinetic parameters, kcat and Km, were deter-
mined as the mean of at least two independent measurements. The interassay
CV was ;8%.
Fluorescence emission spectra at 450 nm (lex¼ 340 nm)were recorded in
a 1-cm quartz cell, using an Eclipse spectroﬂuorometer (Varian, Leini, Italy),
equipped with a thermostated cell holder connected to a Varian Cary Peltier
temperature controller.
Kinetic mechanism of ADAMTS13 activity
studied as a function of temperature
The proteolytic cycle of ADAMTS13 should follow Scheme 1:
E1 S%
k1
k1
ES/
k2
E1 P11 P2; (Scheme 1)
where E and ES are the free and Michaelis forms of ADAMTS13, whereas
P1 and P2 are the tyrosine-containing and methionine-containing released
peptide products, respectively. According to the classical Michaelis-Menten
scheme we have (27):
kcat ¼ k2 (1)
Km ¼ ðk11 k2Þ=k1 (2)
hence:
kcat=Km ¼ k1k2=ðk11 k2Þ: (3)
The k2/k1 ratio is the ‘‘stickiness’’ of the substrate, that expresses the
tendency of the substrate to dissociate more slowly from its complex formed
with the enzyme than it reacts to yield products, i.e., k2 . k1. The
temperature-dependence of the rate constants contained in Eqs. 1 and 3
was studied using the Arrhenius relations (28):
kcat ¼ k2exp½ðE2=RÞð1=T  1=T0Þ (4)
where k1 and k2 are the values of k1 and k2 at the reference temperature,
E1 and E2 are the activation energies associated with k1 and k2 andR is the gas
constant (8.314 J/K mol). From the simultaneous analysis of the temperature
dependence of kcat/Km and kcat parameters the values of k1, k1, and k2 can be
obtained together with the corresponding activation energies. Because T0 can
be set to any value, the parameters can be calculated over the entire tem-
perature range studied.
Further analysis according to the Eyring’s transition state theory led to
calculation of the values of the activation enthalpy and entropy pertaining to
the formation of the transition state leading to cleavage of the FRETS-
VWF73 substrate. Accordingly:
lnðkcat=TÞ ¼ ðDHz=RÞð1=TÞ1 ln kB=h1DSz=R; (6)
where kB ¼ Boltzmann’s constant¼ 1.3813 1023 J K1, h is the Planck’s
constant (6.6263 1034 J sec),DHz¼ activation enthalpy (kJ3mol1) and
DSz ¼ activation entropy (J 3 mol1 3 K1). Hence the free energy was
calculated using the relation (29):
DG
z ¼ DHz  TDSz: (7)
In our experiments only steady-state initial velocities of FRETS-VWF73
hydrolysis (hydrolyzed peptide ,10% total substrate) were analyzed to
avoid the problem of inhibition of the ADAMTS13 activity by high
concentrations of released P2 (see below). The FRETS-VWF73 concentra-
tions used in the temperature experiments were between 0.3 and 20 mM, that
allowed in all cases to compute the Michaelis parameters, avoiding the
phenomenon of the inner ﬁlter effect (30), which was evident at concentra-
tions .20 mM. Control experiments were carried out to measure the
temperature-dependence of the emission spectrum of the cleaved FRETS-
VWF73. The temperature-dependence of the Michaelis parameters was
studied from 15C to 45C in the four-buffer system described above at pH
6.00, where the maximum activity was observed.
Effect of pH on FRETS-VWF73/
ADAMTS13 interaction
The effect of pH on FRETS-VWF73 hydrolysis by ADAMTS13 was in-
vestigated using substrate concentration ,Km of the reaction. Under this
condition, the kinetics of substrate hydrolysis was followed at selected time
intervals to compute the pseudo-ﬁrst order rate constant of the reaction, kobs,
that was equal to the relation kobs ¼ (kcat/Km)e (27), where e is the total
concentration of ADAMTS13. The ﬂuorescence signals were thus trans-
formed in product concentration observed at each time point, Pt, as indicated
above. These valueswere ﬁtted to the equationPt¼ Pmax (1 exp[kobs3 t]),
where Pmax is the maximum concentration of released product at time ¼N.
The effect of pH on the observed kcat/Km values of FRETS-VWF73 hy-
drolysis was analyzed, assuming the existence of two ionizable groups in-
volved in catalysis. Accordingly (27):
kcat=K
obs
m ¼ ½ðk13P1Þ=ð11P1Þ  ½ðk1  k2Þ3P2=ð11P2;
(8)
where k1 is the maximum value of kcat/Km corresponding to the middle pH
form, k2 is the value of kcat/Km corresponding to the high pH form, P1 ¼
alog(pH pKa1) and P2¼ alog(pH pKa2) and pKa1 and pKa2 are the acidic
and basic pKa values controlling the catalytic activity of ADAMTS13. In this
analysis, it was assumed that low pH species has no activity. This assumption
was based on the known function of His residues that chelate the catalytic
kcat=Km ¼ k1k2exp½ððE11E2Þ=RÞð1=T  1=T0Þfk1 exp½ðE1=RÞð1=T  1=T0Þ1 k2exp½ðE2=RÞð1=T  1=T0Þg; (5)
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Zn21. In fact, at pH ,5 the protonation of the His imidazole side chain
affects the interaction with Zn21, blocking the catalytic cycle
The values of kcat/Km were then analyzed as a function of pH at six dif-
ferent temperatures ranging from 15C to 37C by a nonlinear least-square
ﬁtting procedure. The pKa values of the ionizable groups derived from the
ﬁtting procedure were analyzed by the Van t’ Hoff relation (31) to calculate
the values of the ionization enthalpy of the groups involved in the catalytic
process. All analyses were carried out using the software Graﬁt (Erithacus,
Horley Surrey, UK).
Experimentally, the pH-dependent changes of kcat/Km values were studied
using a micromethod using 200 ml of total solution containing 0.5 nM
ADAMTS13 and 1–2mMof the FRETS-VWF73 substrate in the four-buffer
system described above, analyzing 25 different pH values, ranging from 4.50
to 10.50. The stability of the puriﬁed ADAMTS13 over the pH range studied
was conﬁrmed previously through incubation of the enzyme for 180 min in
buffer at a given pH. The initial velocity of hydrolysis of 1 mM FRETS-
VWF73 by ADAMTS13 without previous incubation and after 180 min
incubation in the four buffer system at pH spanning from 4.50 to 10.5 showed
that only at extreme pH values (4.50 and 10.5).the activity of the incubated
enzyme was 7% lower than that observed in not incubated ADAMTS13.
Based on the limited loss of activity, no systematic correction was applied to
the kinetic data. All the enzymatic assays were followed in a Varian Eclipse
spectroﬂuorometer, equipped with a microplate reader, using 96-well poly-
styrene microplates (Corning nonbinding surface). This experimental strat-
egy allowed us to follow simultaneously the course of the substrate’s
hydrolysis under different pH values, thus minimizing the error arising from
interassay variability.
Effect of the Met1606-Arg1668 peptide on the
hydrolysis of the FRETS-VWF73 by ADAMTS13
Recent ﬁndings showed that the C-terminal region of the VWF-73 peptide
spanning from Glu1660 to Arg1668 is engaged in interaction with the spacer
domain of ADAMTS13 and inhibits the hydrolysis of the VWF-73 peptide
(32,33). This effect was investigated in this study as a function of pH, using
puriﬁed different synthetic peptides contained in the VWF-73 substrate, such
as Met1606-Phe1654, Met1606-Leu1657, Met1606-Ala1661, Met1606-Leu1664, and
Met1606-Arg1668. Based on the experimental ﬁndings (see Results), the effect
of the Met1606-Arg1668 peptide on FRETS-VWF73 was best analyzed using
an expanded form of Scheme 1, as follows:
E1 S ! Ks
k1
ES
!k2 E1 P11 P21 I
Kih aKih
EI1 S ! aKs EIS !bk2 EI1 P11 P2
;
(Scheme 2)
where a and b are the factors by which Ki and k2 change, respectively, when
the ternary complex EIS is formed, and Ks is the dissociation binding
constant of the substrate. Notably, for the principle of thermodynamic
balance we obtain that Ks 3 aKi ¼ Ki 3 aKs. Thus, when Km of FRETS-
VWF73 hydrolysis approaches Ks (for instance at T $ 25C), the former
parameter changes as a function of I concentration by the same factor a, as Ki
does as a function of FRETS-VWF73 concentration. This effect was veriﬁed
in our experimental set up at pH 7.50 and 25C. Thus, the initial velocities of
VWF-73 hydrolysis by ADAMTS13 were ﬁtted to the following equation,
according to a classical scheme of hyperbolic mixed-type inhibition (34):
vi ¼ kcatE S Z0=½ðKm Z1Þ1 ðS Z2Þ; (9)
where
Z
0 ¼ 11 ðbI=aKiÞ
Z
1 ¼ 11 ðI=KiÞ
Z
2 ¼ 11 ðI=aKiÞ:
Hydrolysis of FRETS-VWF73 was analyzed by RP-HPLC. Brieﬂy, at the
end of incubation, stopped by 100 mM EDTA, the solutions was chromato-
graphed on a C18 RP-HPLC column (RP-318 column, 5-mm pore size; Bio-
Rad, Milano, Italy), using the following conditions: 10% CHCN3 in 0.1%
TFA for 5 min, 10%–50% CHCN3 in 0.1% TFA for 45 min. The eluted
peptides were detected simultaneously both by a UV/VIS spectrophotomet-
ric device at 210 nm (model 2075, Jasco, Easton, MD) and spectroﬂuoro-
metric detector (FP-2020, Jasco) using a lexc¼ 280 nm and a lem¼ 340 nm.
The initial velocities were taken by a linear regression of the ﬁve concen-
trations of FRETS-VWF73 measured as a function of time (with r . 0.92),
when ,5% substrate was hydrolyzed by ADAMTS13. This experimental
procedure was adopted to avoid product inhibition phenomena. The refer-
ence curve for the conversion of the spectroﬂuorometric signals into
concentration of cleaved substrate was carried out as described previously
for the FRETS method. The effect of Met1606-Arg1668, over a concentration
range from 0.5 to 16 mM, was studied at pH 6.0, 7.50, and 9.50 at 25C,
whereas the other peptides were studied at only pH 7.50 using a maximal
concentration of 20 mM.
Modeling of FRETS-VWF73 and spacer domain
of ADAMTS13
The FRETS-VWF73 peptide was modeled using its primary sequence ho-
mology to the VWF A3 domain and the coordinates for the crystal structure
of this domain (Protein Data Bank, code 1atz), according to the method
detailed previously (14). The model of the ﬁnal three-dimensional structure
was built using the modeling package MODELLER, which satisﬁed the
spatial restraints (36). The prediction of the secondary structure of the spacer
domain of ADAMTS13 was produced using its primary sequence from
Ser556 to Ala685 and the PsiPred and DisoPred programs (36–38).
RESULTS
Temperature studies
The ﬂuorescence signal was inversely correlated to temper-
ature, decreasing by ;0.6 ﬂuorescence units/1C under the
experimental conditions of the study (see Figs. S1 and S2 in
Data S1). Based on this ﬁnding, the reference curve to cal-
culate the concentration of the product from the raw ﬂuo-
rescence data was constructed at each temperature. In our
system, at 25C and pH 6.0 the values of kcat and Km of
FRETS-VWF73 hydrolysis by ADAMTS13 were 2.54 6
0.03 sec1, and 4.6 6 0.2 mM, respectively, in good agree-
ment with previous ﬁndings (32,33,39). The kcat values were
linearly correlated to temperature, as expected for a simple
A/ B reaction following the Arrhenius law. Thus, the kcat
value reﬂects the k2 rate constant of Scheme 1. By contrast,
this was not the case for the Km values, and consequently for
kcat/Km as well, as shown in Fig. 1. Simultaneous ﬁtting to
Arrhenius equations (Eqs. 4 and 5) of experimental values
of both kcat and kcat/Km of FRETS-VWF73 hydrolysis al-
lowed the computation of the kinetic rate constants and the
relative activation energies, listed in Table 1. It is conspicu-
ous that E1 . E2, indicating that the activation energy of
FRETS-VWF73 dissociation from ADAMTS13 is higher
than that needed for its hydrolysis. The ‘‘stickiness’’ of
FRETS-VWF73 (k2/k1) changed as a function of tempera-
ture, showing values listed in Table 1. At temperatures,25C
Mechanistic Studies on ADAMTS-13 2453
Biophysical Journal 95(5) 2450–2461
FRETS-VWF73 acts a sticky substrate, being the rate con-
stant for its breakdown comparable or even higher than that
for its dissociation from the active site of the enzyme. This is
not the case at 37C, as can be inferred from results reported
in Table 1. At this temperature, in fact, the k2/k1 ratio was
0.1 and, in virtue of Eq. 3, the value of kcat/Km is about
10-fold lower than that of k1. Moreover, being k1 . k2 at
T$ 25C, in virtue of Eq. 2,Km approaches progressively the
value of Kd, that is the real equilibrium dissociation constant
of FRETS-VWF73 binding to ADAMTS13. Over the tem-
perature range from 15C to 45C, the Eyring’s plot for the
reactions of FRETS-VWF73 with ADAMTS13 shown in
Fig. 2, allowed us to calculate the relevant activation ther-
modynamic parameters pertaining to the kinetic scheme of
FRETS-VWF73 cleavage. The values of these parameters
were: DHz¼ 286 1.1 kJ/mol, DSz¼1446 3.1 kJ/mol K.
At 25C, DGz ¼ 70.9 6 4 kJ/mol.
Effect of pH on kcat/Km of FRETS-VWF73
hydrolysis by ADAMTS13
Control experiments showed that the ﬂuorescence signals
were not appreciably affected by pH ranging from 4.5 to 10.5.
Under the pseudo-ﬁrst conditions of this study, the time
course of FRETS-VWF73 cleavage allowed to reliably cal-
culate the kcat/Km value of the reaction, as shown in Fig. 3.
Analysis of the pH-dependence of kcat/Km values at each tem-
perature (Eq. 8) over the pH range from 4.5 to 10.5 showed
that two ionizable groups in the free form of the enzyme are
involved in the catalytic cleavage of the FRETS-VWF73
peptide, as shown in Fig. 4 a. For Zn21-ADAMTS13, the
calculated pKa1 value of 6.41 6 0.08 at 25C is compatible
with a histidine group. The pKa value of this group could be
theoretically assigned even to a group of unliganded FRETS-
VWF73. However, the absence of a histidine residue in the
sequence of the substrate allowed to rule out such an in-
volvement. We know that three His residues are present in the
catalytic site of ADAMTS13 in the sequence His224Glu-Ile-
Gly-His228-Ser-Phe-Gly-Leu-His234, where His224, His228,
and His234 should be engaged in the coordination of the zinc
ion. The latter should be coordinated by a fourth ligand,
which is hypothesized to be a water molecule bound to a zinc
ion. The Van t’ Hoff analysis of the pKa1 values showed that
the standard enthalpy of its ionization was equal to 32.5 6
1.8 kJ/mol, as shown in Fig. 4 b. The results of these tem-
perature studies are consistent with the assignment of the
FIGURE 1 Arrhenius plot of kcat (A) and kcat/Km (B) values of FRETS-
VWF73 hydrolysis by ADAMTS13. The continuous lines were drawn
according to Eqs. 4 and 5, with the best-ﬁt parameter values listed in Table 1.
In all the data sets the vertical bars represent the SD from two different
determinations.
FIGURE 2 Eyring plot of kcat values of FRETS-VWF73 hydrolysis by
ADAMTS13. The slope (r ¼ 0.996) and the intercept allowed to calculate
the relevant activation thermodynamic parameters: DHz ¼ 286 1.1 kJ/mol,
DSz ¼ 144 6 3.1 J/mol K. At the standard temperature of 25C, DGz ¼
70.9 6 4 kJ/mol.
TABLE 1 Kinetic and thermodynamic parameters for the
reaction of ADAMTS13 with FRETS-WF73
T (C) k1 (M1 sec1) k1 (sec1) k2 (sec1) k2/k1
15 4.40 6 0.2 3 105 0.61 6 0.2 1.50 6 0.06 2.45
20 7.90 6 1.3 3 105 1.64 6 0.6 1.89 6 0.06 1.15
25 1.39 6 0.4 3 106 4.10 6 1.9 2.30 6 0.05 0.56
30 2.39 6 0.6 3 106 10.00 6 5.7 2.86 6 0.05 0.29
35 3.96 6 29 3 106 23.70 6 13 3.48 6 0.06 0.15
40 6.70 6 4 3 106 56.20 6 38 4.21 6 0.1 0.074
45 7.31 6 5 3 106 70.50 6 42 5.10 6 0.16 0.073
The activation free energy of k11 (E1), k1 (E1), and k2 (E2) was equal to
81.5 6 20 kJ/mol, 135 6 16 kJ/mol, and 30.5 6 1.6 kJ/mol, respectively.
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general acid either to a H-N2(His) atom or a metal-bound
water molecule (40). To overcome this uncertainty, we
measured the pKa of the ionizable group involved in the
catalytic mechanisms of the Co21-substituted ADAMTS13.
The process of Zn21 extraction from the native enzyme did
not alter its functional properties, as the reconstitution of the
Zn21-ADAMTS13 from apo-ADAMTS13 was reversible
and generated again an enzyme with values of kcat and Km of
FRETS-VWF73 hydrolysis very close to those of the native
form (kcat of 2.1 6 0.3 vs. 2.4 6 0.2 sec
1, and Km of 4.5 6
0.5 mM vs. 4.86 0.4 mM, respectively). Co21-ADAMTS13
showed at pH 6.00 a reduced kcat/Km compared to that of the
Zn21-ADAMTS13. This effect was caused by a minimal
change of Km (5.1 vs. 4.8 mM) and a signiﬁcant decrease of
kcat value (1 vs. 2.4 sec
1). It is noteworthy that substitution
of zinc with nickel ion caused a much more marked decrease
of the peptidase activity of ADAMTS13, which was almost
inactive in the FRET assay. The replacement of metal ions
in the active site of ADAMTS13 in studies concerning the
pH-dependent amidase activity provided useful elements to
try unraveling of the assignment of this ionizable group
involved in the catalytic machinery. Theoretical and ex-
perimental studies showed that a metal ion-dependent shift
in pKa for metalloproteases reﬂects the ionization of the
metal-coordinated water molecule bound to enzyme (41).
On the contrary, the same pKa value for different metal-
substituted metalloproteases was shown to be due to a
critical amino acid at the active site of the protease involved
and not to an enzyme-metal-water complex (42). As shown
in Fig. 4 a, the analysis of the kcat/Km values of FRETS-
VWF73 hydrolysis by Co21-ADAMTS13 as a function of
pH showed a signiﬁcant change of the pKa value of the
Co21-substituted enzyme from 6.41 6 0.08 in the Zn21-
ADAMTS13 to 6 6 0.09 in the Co21-substituted enzyme.
Thus, both the value of the standard ionization enthalpy
equal to 28 kJ/mol, which is typical of water molecules (43),
and the intrinsic pKa value provided functional evidence
that the pKa value of 6.41 of Zn
21-ADAMTS13 derives
FIGURE 3 Examples of the kinetics of FRETS-VWF73 cleavage (1 mM)
by 0.5 nM ADAMTS13 in the four-buffer system solution at pH 5.0 (n) and
10.0 (d) and T¼ 25C. For sake of clarity, the ﬂuorescence signal at time¼
Nwas set at 100% and corresponded to 1 mM cleaved FRETS-VWF73. The
continuous lines were drawn according to a simple ﬁrst order kinetics with
the best-ﬁt kcat/Km values equal to 5.2 6 0.1 3 10
5 M1 sec1 and 2.03 6
0.06 3 105 M1 sec1 for pH 5 and 10, respectively.
FIGURE 4 (A) Effect of pH on kcat/Km values of FRETS-VWF73 hy-
drolysis by both Zn21-ADAMTS13 (d) and Co21-ADAMTS13 (s) at
25C. The continuous lines were drawn according to Eq. 8, with the best-ﬁt
pKa values of 6.41 6 0.08 and 4 6 0.1 for Zn
21-ADAMTS13 (k1 ¼ 5.9 6
0.093 105 M1 sec1, k2¼ 1.996 0.033 105 M1 sec1) and 6.016 0.09
and 4.16 0.13 (k1 ¼ 3.26 0.083 105 M1 sec1 and k2 ¼ 0.986 0.023
105 M1 sec1) for Co21-ADAMTS13. (B) Van t’ Hoff plot of the pKa1 of
the ionizable group involved in the catalytic cycle of ADAMTS13. The
straight line was drawn with the best-ﬁt DH value equal to 32.5 6 1.8 kJ/
mol. (C) Van t’ Hoff plot of the pKa2 of the ionizable group involved in the
catalytic cycle of ADAMTS13. The straight line was drawn with the best-ﬁt
DH value equal to 3.8 6 0.4 kJ/mol.
Mechanistic Studies on ADAMTS-13 2455
Biophysical Journal 95(5) 2450–2461
from the metal-bound water molecule at the active site of the
enzyme.
The second ionizable group involved in ADAMTS13 ca-
talysis exhibited a lower pKa value, equal to ;4 for both
Zn21- and Co21-ADAMTS13 (Fig. 4 a). The standard en-
thalpy of ionization was equal to 3.8 6 0.4, as shown by a
van’t Hoff plot in Fig. 4 c. This value is typical for ionization
of a carboxylate group (44). Due to the presence of a gluta-
mate at position 225 of ADAMTS13, in the region engaged
in the coordination of the catalytic zinc ion, we could rea-
sonably assign to Glu225 the pKa2 value measured in these
experiments.
Inhibition of ADAMTS13 by the
Met1606-Arg1668 peptide
Extensive analysis of the experimental data set pertaining to
the inhibitory effect of Met1606-Arg1668 peptide on FRETS-
VWF73 hydrolysis by ADAMTS13 showed that this phe-
nomenon was best described by a hyperbolic mixed-type
mechanism. Two other models were analyzed: 1) a pure
noncompetitive inhibition, and 2) a linear mixed-type inhi-
bition (45). The minimization procedure provided in fact a
reduced x2 equal to 4.454 3 104 for the hyperbolic mixed-
type, 1.6  103 for the linear mixed-type, and 4.86 3 103
for the noncompetitive inhibition model. F-testing of the
results obtained at pH 6.0 with the hyperbolic and linear
mixed-type inhibition model gave a probability value ¼ 33
106, thus showing that Eq. 9 expresses the best model for
the experimental data. The interaction of the Met1606-Arg1668
was characterized by a signiﬁcant afﬁnity, showing at pH 6.0
and 25C aKi value equal to;1mM, whereas a and b values
were equal to 10 and 0.23, respectively, as shown in Fig. 5 a.
These results are in agreement with a model where binding of
the Met-containing peptide allosterically decreases by a
factor10 the afﬁnity of the FRETS-VW73/ADAMTS13 in-
teraction, and reduces 4-fold the kcat value of the substrate
cleavage. These effects are possible only if P2 in Scheme 2,
binds to an exosite, distinct from the active site of the en-
zyme, whose ligation is able to affect the interaction with the
substrate and the catalytic mechanism of the protease. The
values of Ki, a, and b changed slightly but signiﬁcantly as a
function of pH in a range from 6.0 to 9.5 (Fig. 5, b–d). A trend
to an increase of both Ki and b, and a decrease of a values
was observed (Fig. 5, b–d). This result suggests that the in-
teraction of P2 with ADAMTS13 involves the side chain of
basic residues, and thus has a tendency to be weaker and to
affect less efﬁciently the catalytic mechanisms at pH values
.7.5. The use of shorter C-terminal VWF73 peptides, such
as Met1606-Phe1654, Met1606-Leu1657, Met1606-Ala1661, and
Met1606-Leu1664, variably inhibited the hydrolysis of
FRETS-VWF73 (Fig. 6 a). In particular, a strong inhibition,
approaching that one exerted by Met1606-Arg1668, was ob-
served particularly when the peptides contained in their se-
quence Ala1661 and Leu1664 (Fig. 6 b).
FIGURE 5 (A) Inhibition of ADAMTS13-catalyzed hydrolysis of
FRETS-VWF73 by Met1606-Arg1668 peptide used at the following concen-
trations: (O) zero, (d) 0.5 mM, (h) 1 mM, (n) 2 mM, (D) 4 mM, (:) 8 mM,
(=) 16 mM. The experiment was carried out in four-buffer system (see text)
at pH 7.50. Fifty-six experimental points were simultaneously ﬁtted to a
hyperbolic mixed-type inhibition equation (Eq. 9) with the best-ﬁt parameter
values kcat ¼ 2.16 0.02, Km ¼ 66 0.2 mM, a ¼ 106 1, b ¼ 0.236 0.02.
The vertical bars represent the SD from two different determinations. In the
other panels the effect of pH on Ki (B), a (C), and b (D) parameter values of
Eq. 9. are shown. The vertical bars represent the SD from two different
determinations.
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DISCUSSION
Some relevant ﬁndings emerged from this study: 1), two
ionizable residues control the catalytic activity of
ADAMTS13 toward FRETS-VWF73 over the pH range
from 4.5 to 10.5; and 2), the pKa of one group involved in the
catalytic cycle can be reasonably assigned to the metal-bound
water molecule, which generates the hydroxide species re-
sponsible for the cleavage of the substrate’s peptide bond.
Based on the ﬁndings in this study, the metal-bound water
molecule is the natural candidate to act as a conduit for proton
transfer (46). These results showed that the acidity of this
ionizable group is dependent on the metal involved, and,
from both theoretical and experimental standpoint, this be-
havior is typical of coordinated water molecules (41,43,47).
The H2O molecule bound to the ‘‘harder’’ Zn
21 ion, would
render the metal-aquo complex a stronger Lewis acid than
coordination to the ‘‘softer’’ Co21 ion. About the almost
complete inhibition of ADAMTS13 caused by Ni21 insertion
into the catalytic site, we hypothesize that this effect is con-
sistent with a distorted tetrahedral coordination geometry of
the metal ion, which is incompatible with an efﬁcient align-
ment with the scissile bond.
Thus, the Zn21 ion present in the catalytic site of
ADAMTS13 and coordinated by His224, His228, and His234,
should be coordinated by the fourth ligand represented by a
bound water molecule, which undergoes the metal-catalyzed
dissociation:
Zn
21 1H2O/Zn
21
OH
1H1 (10)
The hydroxide species generated in the reaction acts as a
nucleophile and attacks the peptide bond to be hydrolyzed
(48). The ﬁndings that substitution of Zn21 with Co21 at the
active site of ADAMTS13 causes a decrease of both the kcat
value and the pKa value of the group involved in catalysis are
in agreement with this mechanism. Ionization of His residues
coordinating the zinc ion in the catalytic site could obviously
contribute to the measured pKa1 value. The second ionizable
group with a pKa ﬃ 4 is likely represented by Glu225,
contained in the active site sequence from His224 to His234
bearing the residues coordinating the zinc ion. We could
predict that a favorable hydrogen bond between this gluta-
mate and the metal-bound water molecule would make the
latter more nucleophilic. Compared to cobalt and nickel, zinc
was the most efﬁcient metal to ionize the catalytic water
molecule responsible for the proteolytic activity of
ADAMTS13. This effect likely depends also from the coor-
dination geometry of metal ion and the position of the metal-
bound water molecule. In fact, other metalloproteases, such
as carboxypeptidase A and thermolysin, showed a higher
catalytic speciﬁcity in the cleavage of their substrates upon
the exchange of zinc with cobalt (41,49).
Although it is very likely that the acidic pKa of the second
catalytic residue could be assigned to Glu225, as indicated in
the Results section, we need to carefully interpret the ex-
perimental results. In fact, at pH ,5 the protonation of the
His imidazole side chain could affect the interaction with the
zinc ion and consequently the catalytic cycle. These studies
on the effect of temperature allowed us to have an estimate of
the relevant kinetic rate constants and the relative activation
energies of the catalytic steps of FRETS-VWF73 hydrolysis.
In particular, from data listed in Table 1, it can be deduced
that FRETS-VWF73 acts as a sticky substrate at pH 6.0 under
temperatures,25C, being the rate constant for the substrate
dissociation from the active site comparable or even lower
than that of its cleavage. This behavior renders the value of
the kcat/Km similar to that of association rate constant of the
substrate binding to the active site of ADAMTS13. By
FIGURE 6 (A) Inhibition of ADAMTS13-catalyzed hydrolysis of
FRETS-VWF73 by 20 mM of each of these VWF-derived peptides:
Met1606-Phe1654 (d), Met1606-Leu1657 (h), Met1606-Ala1661 (n), Met1606-
Leu1664 (D), and in absence of any peptide (O). The best ﬁt kcat and Km
values were 2.09 6 0.09 sec1 and 5.83 6 0.9 mM, respectively, for
Met1606-Phe1654 (d), 1.63 6 0.07 sec1 and 5.83 6 0.97 mM for Met1606-
Leu1657 (h), 1.21 6 0.04 sec1 and 22 6 1.7 mM for Met1606-Ala1661 (n),
1.046 0.06 sec1 and 306 3.7 mM for Met1606-Leu1664 (D). The best ﬁt kcat
and Km values were equal to 2.21 6 0.05 sec
1 and 6.9 6 0.06 mM in the
absence of peptides (O). The vertical bars represent the SD from two
different determinations. (B) Bar graph showing the measured kcat/Km values
for hydrolysis of FRETS-VWF73 in the presence of 20 mM of the various
C-terminal peptides of VWF73. The number reported for each peptide
species refers to the number of the last amino acid in the peptide sequence,
starting from Met1606. The vertical bars represent the SD from two different
determinations.
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contrast, at temperatures.25C the dissociation rate is much
higher than that of the cleavage rate, and the value of kcat/Km
is about 10-fold lower than that of the association rate con-
stant.
Furthermore, application of the Eyring’s transition theory
showed that theDSz value is strongly negative. The activation
entropy is a macroscopic quantity that includes a number of
microscopic contributions by both the reactants and solvating
molecules. Activation entropies are in many cases dominated
by solvent reorganization effects (34). Activation entropy of
catalytic interaction between VWF and ADAMTS13 is
strongly negative, indicating that the transition state of this
bimolecular interaction becomes more ordered by reducing
considerable translational and rotational degrees of freedom
of motion of the reactants. This result implies that the for-
mation of the transition state requires the enzyme and the
substrate to adopt discrete and precise conformations and
solvent orientation. Thus, these ﬁndings indicate that
ADAMTS13 recognizes and cleaves the Tyr-Met peptide
bond in the A2 domain of VWF by lowering the activation
entropy of the reaction due to positioning the two reactants
and ordering metal-bound water in the active site. This
mechanism is in accord with the extraordinary chemical and
conformational speciﬁcity, which characterizes the catalytic
interaction between VWF and ADAMTS13.
This mechanism is facilitated by the interactions of
FRETS-VWF73 with exosites of the enzyme, that contribute
to its correct and productive binding so that the catalytic
water molecule is perfectly aligned toward the scissile bond
of the substrate. Notably, the C-terminal product of
ADAMTS13 hydrolysis, that is Met1606-Arg1668 peptide, is
able to bind with considerable afﬁnity to ADAMTS13 and to
inhibit it with a hyperbolic mixed-type mechanism. This re-
sult is in agreement with recent ﬁndings, showing that this
VWF peptide binds to the spacer domain of ADAMTS13
(32,33). The experiments reported in this study show that the
binding of FRETS-VWF73 to the enzyme reduces 6- to
10-fold the afﬁnity of the Met1606-Arg1668 peptide and vice-
versa. The binding afﬁnity of the Met1606-Arg1668 peptide
tends to decrease and have lower allosteric effects on both
kcat (resulting in higher b values) and Km (resulting in lower
a values) at pH .7.5, as shown in Fig. 5, b–d. No histidine
residues are present in the Met1606-containing peptide se-
quence, whereas in the spacer domain (Ser556-Ala685 se-
quence) two histidine residues are present at position 1588
and 1594. Although the latter groups could be involved in the
pH-dependence of the Met-containing peptide binding, a
signiﬁcant increase of the Ki of the Met-containing peptide
occurs at pH . 8.5, where such groups should be already
completely not protonated. This suggests the involvement in
this interaction of ionizable residues with more basic pKa
values. Thus, the side chain of lysine or arginine residues
may be engaged in this interaction. The molecular model of
the FRETS-VWF73 and the prediction of the secondary
folding of the spacer domain of ADAMTS13 provided some
elements that could be useful to interpret these functional re-
sults from a structural point of view. These models showed
that FRETS-VWF73 has an overall C-shaped scaffold (403
40325 A˚) with a helical C-terminal domain fromD1653
to R1668 (Fig. 7). The FRETS-VWF73 molecule is mostly
acidic (theoretical pI¼ 4.4), containing 6 basic and 11 acidic
residues. Most of the charged residues are located after the
Tyr1605-Met1606 bond, such as the cluster composed of
Asp1614 (VWF numbering system; Asp19 in the sequence of
the peptide), Lys1617, Arg1618, Glu1638, and Glu1640, which
cover a surface area of ;400 A˚2. Likewise, another mostly
acidic cluster is composed of Asp1653, Glu1655, Glu1660,
Asp1663, and the polar hydroxyl residue of Thr1656. These
residues, as mentioned previously, are contained in a helix
located at the C terminus of the peptide and, as shown by the
three-dimensional model, oppose the Tyr1605-Met1606 pep-
tide bond cleaved by ADAMTS13 at a mean distance of
;18/20 A˚ (Fig. 7, inset). The experimental ﬁndings shown in
Fig. 6, a and b, showed that the product’s region fromGlu1660
and Arg1668 is necessary for an efﬁcient inhibition of
FIGURE 7 Three-dimensional molecular model of FRETS-VWF73. The
residues 1 and 73 in FRETS -VWF73 refer to the primary sequence of the
peptide substrate, whereas they correspond to residues Asp1596 and Arg1668
of VWF, respectively. The sequence from Thr1656 to Arg1668 in FRETS-
VWF73 (VWF numbering system, Thr61 and Arg73, respectively, in the
primary sequence of FRETS-VWF73) are shown as ﬁlled space. In the
FRETS-VWF73model the side chain of both Tyr1605 and Met1606 are shown
as black sticks. In the inset, the model of the peptide is shown as strands in
the same orientation.
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ADAMTS13, in agreement with recent studies (32). Thus,
this helical region would bind to a part of the spacer domain
using considerable ionic and polar interactions for the mo-
lecular recognition. Without known three-dimensional
structures homologous to the spacer domain of ADAMTS13,
just a secondary structure prediction of this region can be
given in consideration of the lack of cysteine residues, and
thus of constraints dictated by the disulﬁde-bonding con-
nectivity. The ADAMTS13 spacer domain is positively
charged (theoretical pI ¼ 9.51), containing 15 (11.5%) Arg
and three (2.3%) Lys residues. The secondary structure pre-
diction carried out by the PsiPred program showed that this
domain should be mostly composed of strands (see Fig. S3 in
Data S1) with more disordered regions only at the ends of
N- and C-terminal regions. As a consequence, this domain
should assume mainly a stretched conﬁguration. This ﬁnding
is in agreement with the ‘‘connecting’’ nature of this domain,
which links the metalloprotease/disintegrin/Cys-rich domain
with the TSP-1 repeats of the enzyme (5). Moreover, this
domain should be extensively exposed to solvent, as it rep-
resents often the main target for auto-antibodies produced in
immunomediated thrombotic microangiopathies (50). At its
maximal theoretical extension the spacer domain is 195 A˚
long, so we can predict from simple geometrical consider-
ations that only the N-terminal region extending from Ser1556
to Ala1586 and containing three Arg and one Lys residues
could interact with the acidic C-terminal region of FRETS-
VWF73. Based on these biochemical and modeling results, it
is likely that the enzyme has a C-shaped scaffold, so that the
spacer domain should oppose the active site of the metallo-
protease to accommodate the entire FRETS-VWF73 mole-
cule that, according to the model reported in Fig. 7, has a
similar and complementary C-shaped conformation. Due to
dimensions of the various enzyme domains and the confor-
mation of the VWF73 substrate, only this particular tertiary
structure of ADAMTS13 could allow an efﬁcient interaction
with FRETS-VWF73. Notably, the C-shaped scaffold was
also observed in the recently solved structure of ADAMTS-1,
where the Cys-rich domain, ﬂanking the spacer region of the
metalloprotease in the ADAMTS family, stacks against the
active site of the enzyme (51). The charged residues of both
VWF and ADAMTS13 could serve to preorient correctly the
enzyme and the substrate. The interaction with the spacer
domain would favor the molecular recognition of VWF. This
conclusion was also supported by the ﬁnding that a shorter
FRETS-VWF substrate (from Asp1596 to Phe1654) was min-
imally recognized and hydrolyzed by ADAMTS13, at pH
6.00 and 37C (data not shown). The involvement of this
exosite favors a correct and efﬁcient orientation of the VWF
molecule toward the catalytic pocket of ADAMTS13, where
the zinc-bound water molecule can properly face the scissile
Tyr-Met bond, carrying out the catalytic cleavage. More-
over, once sufﬁcient concentrations of C-terminal product is
formed, binding of the C-terminal cleaved product to the
spacer domain induces an inhibitory allosteric control of the
ADAMTS13 activity, likely aimed at limiting an excessive
loss of high molecular weight multimers of VWF. The rele-
vance of the VWF Met1606-Arg1668 sequence for the mo-
lecular recognition by the protease is also shown by the
strong inhibitory effect exerted by auto-antibodies, which
interact with the spacer domain of ADAMTS13, often pre-
sent in thrombotic microangiopathies (50).
Notably, a recent study with recombinant VWF constructs
carrying mutations responsible for the occurrence of a type
2A Von Willebrand disease showed that these VWF mole-
cules are characterized by an exalted hydrolysis by
ADAMTS13 (7). Among these VWF molecules, the authors
indicated several mutations located in the region from
Met1606 to Arg1668 such as Val1607Asp, Gly1609Arg,
Ile1628Thr, Gly1629Glu, Gly1631Asp, and Glu1638Lys (7).
Based on the results of this study, we can hypothesize that
these mutations, and especially the charge reversal at position
1638 of VWF, affect the interaction of VWF with the spacer
domain of ADAMTS13, thus perturbing the negative feed
back mechanism of VWF cleavage described above and fa-
voring its degradation
In conclusion, the study of the pH- and temperature-
dependence of the ADAMTS13 activity provided novel
ﬁndings to address the knowledge of the intermediate steps of
the catalytic cycle of the metalloprotease. Furthermore, the
Met-containing peptide produced by cleavage at the Tyr1605-
Met1606 peptide bond is able to allosterically inhibit the en-
zyme’s function. In this study, we showed that pH-dependent
interactions between acidic residues from Met1606 and
Arg1668 of VWF A2 domain and basic residues of the spacer
domain of ADAMTS13 play a central role in this allosteric
mechanism. Further studies are needed to assess whether the
binding of particular auto-antibodies to the spacer domain of
ADAMTS13, responsible for acquired forms of thrombotic
microangiopathies, could directly trigger this allosteric
mechanism, inhibiting the interaction with VWF multimers.
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